Spero Therapeutics
Clinical trials sponsored by Spero Therapeutics, explained in plain language.
-
New pill fights tough lung infection in early trial
Disease control CompletedThis study tested an experimental oral medication called SPR720 for people with MAC lung disease, a difficult-to-treat bacterial infection. Researchers compared different doses of SPR720 against a placebo in 25 patients to see if it could reduce the bacteria in their lungs and im…
Phase: PHASE2 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Pill could replace IV drips for serious infections
Disease control CompletedThis large, completed Phase 3 study compared a new oral antibiotic pill to a standard intravenous (IV) antibiotic for hospitalized adults with serious kidney or urinary tract infections. The goal was to see if the pill worked just as well to cure the infection and clear the bacte…
Phase: PHASE3 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC